FMI
CYTK icon

F/M Investments’s Cytokinetics CYTK Stock Holding History

F/M Investments’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.19M Buy
60,891
+31,303
+106% +$2.25M 0.26% 75
2026
Q1 		$1.95M Buy
+29,588
New +$1.88M 0.13% 106

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

F/M Investments's CYTK Position: Q2 2026 in Review

F/M Investments increased its Cytokinetics (CYTK) stake by 106% in Q2 2026, buying an estimated $2.25M and bringing the position to 60,891 shares worth $5.19M. The position accounts for 0.26% of the portfolio, ranked #75.

F/M Investments first reported a position in CYTK in Q1 2026 and has held it in 2 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • F/M Investments held 60,891 shares of Cytokinetics worth $5.19M as of Q2 2026.
  • F/M Investments bought 31,303 Cytokinetics shares in Q2 2026, an estimated $2.25M.
  • Cytokinetics made up 0.26% of F/M Investments's portfolio in Q2 2026, its #75 holding.
  • F/M Investments first reported a position in Cytokinetics in Q1 2026 and has held it in 2 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.